An afternoon snooze might seem appealing to middle-aged folks and seniors, but these naps could carry a high cost.

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Tuesday that Moderna has agreed to a true ...

Although it appears not to cause more severe illness, preliminary data demonstrate that the variant exhibits significant ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...

Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID ...

The Food and Drug Administration has approved a new COVID-19 vaccine. Moderna's new option is a lower-dose version.

The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...